January 7, 2008- Santa Ana, Ca- Robinson Pharma Inc., (RPI) announced that it successfully completed an audit for cGMP compliant manufacture of dietary supplements. The Audit was performed by Shuster, a leading third party testing and quality assurance auditing firm. RPI, the leading soft gel manufacturer in North America, has experienced record growth over the past year and, as part of it its expansion plan, has gained authoritative certification that it complies with cGMP manufacturing standards for dietary supplements.
The Shuster quality systems audit covered all aspects of the manufacturing process and was performed by credentialed experts in quality analysis. Shuster analyzed the RPI Standard Operation Procedures (SOPs), staff qualifications, training program, facility adequacy and cleanliness. All aspects of the manufacturing process were reviewed including receipt and validation of ingredients, the production process, post production product analysis, product handling, packaging, storage, and record keeping. Robinson Pharma Inc., which was recently granted a drug manufacturing license by the state of California, was shown to be in compliance with the standards used by Shuster to evaluate a companies’ compliance with cGMP standards for dietary supplements.
RPI president and founder, Tuong Nguyen stated, “The successful completion of the audit with Shuster demonstrates that Robinson Pharma Inc. is a world class manufacturer of dietary supplements. Our unwavering commitment to produce superior quality product is evidenced by our compliance with Shuster’s high standards for performance. We understand that that the marketplace demands third party validation of manufacturing practices. We partnered with Shuster for this certification because they are respected as an international expert in quality practices.”
“The Shuster certification, as well as the drug manufacturing license, will allow Robinson Pharma pursue important additional market opportunities in 2008. As we gain additional international and domestic clients, certification from Shuster reinforces our quality message” stated Kenn Israel, Vice President of Marketing. “The certification of cGMP compliance compliments our industry leading capacity as the largest soft gel encapsulator in North America and our ability to rapidly complete manufacturing and turn around orders. Our Company understands that the customers demand the right product, on time, at the right price.”
Robinson Pharma Inc. is a Southern California based, drug licensed, full service custom contract manufacturer. RPI features the largest soft gel encapsulation capacity in the US with 22 encapsulation lines producing over 12 billion soft gels per year. Production capabilities include tablet compression, capsule filling, custom imprinting, and a range of packaging options including bottles, blister packaging boxing, and bulk product. Additional services include product development and ingredient sourcing as well as extensive analytical capabilities. Robinson Pharma Inc. provides rapid turnaround on all projects and offers highly competitive pricing. Robinson Pharma Inc. maintains 400,000 square feet of production, operations, and warehousing facilities. For more information please email [email protected], Phone (714) 241-0235 or visit www.RobinsonPharma.com